MetaCap

Bone Biologics (BBLG) vs CollPlant Biotechnologies (OPHI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CollPlant Biotechnologies is the larger company by market cap ($9.6 million vs $909,961), about 10.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBLG-32.89%OPHI-32.54%
+2%-16%-35%
Nov 12, 20261 yearNov 20, 2026
BBLG-17.41%OPHI-14.25%
+1%-9%-18%
Nov 9, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBLG versus OPHI key metrics
MetricBBLGOPHI
Share price$0.2685$3.13
Market cap$909.96K$9.63M
1-day change-2.40%-2.49%
EPS (TTM)$-1.02$-9.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$2.37M
Revenue growth (YoY)—+360.39%
Net income (latest FY)$-3.11M$-11.49M
Gross margin—64.78%
Operating margin—-484.31%
Net margin—-484.56%
52-week high$2.39$22.50
52-week low$0.261$2.64
Distance from 52-week high-88.77%-86.09%
Analyst consensusnone—
Avg. price target upside+4443.76%—
Average volume254.56K385.37K
Shares outstanding3.39M3.08M
Employees2—
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CollPlant Biotechnologies is about 10.6 times larger than Bone Biologics by market value ($9.63M vs $909.96K).

About Bone Biologics

BBLG stock →

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.

Health Care · Industrial Specialties · 2 employees

BBLG vs OPHI FAQ

Which is bigger, Bone Biologics or CollPlant Biotechnologies?

CollPlant Biotechnologies (OPHI) is larger, with a market capitalization of $9.63M compared with $909.96K for Bone Biologics (BBLG).

Are Bone Biologics and CollPlant Biotechnologies in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons